Workflow
New York Times
icon
Search documents
X @Nick Szabo
Nick Szabo· 2026-02-08 08:05
RT Chief Nerd (@TheChiefNerd)David Sacks Asks Why the New York Times is Protecting Reid Hoffman 🤔“The number one person in the Epstein files from Silicon Valley which is Reid Hoffman … stayed at not just the island, but the townhouse and the New Mexico ranch.”“The New York Times clearly has a list of people they consider approved targets. They're all right-coded people like Elon or Peter Thiel … But the people who've donated hundreds of millions of dollars to the Democrat Party and have paid for dirty trick ...
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Picard Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PMI
TMX Newsfile· 2026-02-08 02:34
Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of Picard Medical, Inc. securities during the specified Class Period, highlighting potential compensation for affected investors [1][2]. Group 1: Class Action Details - The class action lawsuit pertains to securities purchased between September 2, 2025, and October 31, 2025 [1]. - Investors who purchased Picard Medical securities during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. Group 2: Legal Process and Participation - Interested investors can join the class action by visiting the provided link or contacting the law firm directly [3][6]. - A lead plaintiff must be appointed by April 3, 2026, to represent the class in court [1][3]. Group 3: Allegations Against Picard Medical - The lawsuit alleges that defendants made materially false and misleading statements and failed to disclose adverse facts about Picard's business and operations [5]. - Specific allegations include involvement in a fraudulent stock promotion scheme, insider trading through offshore accounts, and omission of critical information regarding stock price manipulation [5]. Group 4: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements and recognition in the field [4]. - The firm has recovered hundreds of millions of dollars for investors, with notable achievements in previous years [4].
PMI INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Picard Medical (PMI) Investors of Securities Class Action Deadline on April 3, 2026
TMX Newsfile· 2026-02-07 13:23
Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Picard Medical, Inc. due to allegations of securities law violations, encouraging affected investors to come forward [2][4]. Group 1: Legal Investigation and Claims - The law firm is reminding investors of the April 3, 2026 deadline to seek the role of lead plaintiff in a federal securities class action against Picard Medical [2]. - Allegations against Picard Medical include involvement in a fraudulent stock promotion scheme and misleading public statements regarding the company's financial health [4]. Group 2: Stock Performance and Impact - On October 24, 2025, Picard Medical's shares closed at $5.31, a significant drop from $13.20 on October 23, 2025, representing a decline of $7.89 per share or approximately 59.8% in a single trading session [5]. Group 3: Firm Background - Faruqi & Faruqi, LLP has recovered hundreds of millions of dollars for investors since its establishment in 1995, with offices in New York, Pennsylvania, California, and Georgia [3].
Clear Ads Publishes Implementation Guide as Amazon Opens Ad Platform to AI Agents
TMX Newsfile· 2026-02-06 16:19
Core Insights - Clear Ads has released a guide for sellers to connect AI agents to Amazon's advertising platform via the newly launched Ads MCP Server open beta [1][2] - Amazon's MCP Server, announced on February 2, serves as a translation layer for natural language prompts into structured API calls, streamlining campaign management [2][5] - The implementation of the MCP Server significantly reduces the time required for campaign setup, allowing tasks that previously took 15-20 minutes to be completed with a single text prompt [3][6] Company Insights - Clear Ads specializes in helping e-commerce sellers scale profitably through expert PPC management and AI-powered optimization [7] - The agency manages advertising spend for established brands across the US and Europe, emphasizing the importance of early adoption of the MCP Server for competitive advantage [4][7] Industry Insights - The Model Context Protocol (MCP) is an open standard developed by Anthropic, which simplifies the integration of AI systems with advertising platforms, reducing setup time and ongoing maintenance [6] - The open beta of Amazon's MCP Server includes tools for end-to-end Sponsored Products campaign creation, cross-country campaign expansion, and consolidated performance reporting [5]
The New York Times' Q4 Earnings Beat Highlights Digital Momentum
ZACKS· 2026-02-05 15:51
Core Insights - The New York Times Company (NYT) reported strong performance in Q4 2025, exceeding expectations for both earnings and revenues, with adjusted earnings of $0.89 per share and revenues of $802.3 million, a 10.4% year-over-year increase [1][10] Subscription Performance - NYT experienced healthy subscription momentum, adding approximately 450,000 net digital-only subscribers in the quarter, bringing the total to 12.78 million subscribers, including 12.21 million digital-only subscribers [2][5] - Total subscription revenues increased by 9.4% year over year to $510.5 million, with digital-only subscription revenues rising 13.9% to $381.5 million, despite a 2% decline in print subscription revenues [4][10] Digital Advertising Growth - Total advertising revenues improved by 16.1% year over year to $191.7 million, with digital advertising revenues surging 24.9% to $147.2 million, driven by strong demand from marketers [7][10] Financial Health - The company ended the quarter with cash and marketable securities of $1.2 billion, reflecting an increase of $256 million from the previous year, and had no outstanding debt [12] - Free cash flow for 2025 was $550.5 million, significantly up from $381.3 million in 2024, indicating strong cash generation capabilities [13][14] Future Outlook - Management is optimistic about sustaining growth, projecting digital-only subscription revenues to rise by 14-17% and total subscription revenues to increase by 9-11% in Q1 2026 [6][10] - Total advertising revenues are expected to grow in the low double digits, with digital advertising revenues projected to increase in the high teens to low twenties percentage range [8][11]
X @Nick Szabo
Nick Szabo· 2026-02-05 00:44
RT WikiLeaks (@wikileaks)Epstein Email: “outing” New York Times publisher Sulzberger will see “the end of the establishment.”One month before the abrupt departure of Arthur Ochs ‘Pinch’ Sulzberger Jr as publisher of the New York Times, Epstein wrote to attorney Brad Karp: “How about Sulzberger would that be funny”--to which Karp replied: “That would be pretty ironic and give whole new meaning to his nickname ‘pinch’.”One day after the exchange between Karp and Epstein, Epstein and journalist Michael Wolff d ...
New York Times Shares Drop 7% After Q1 Guidance Overshadows Strong Q4 Results
Financial Modeling Prep· 2026-02-04 20:38
Core Insights - The New York Times Company reported fourth-quarter earnings and revenue that exceeded analyst expectations, but weaker first-quarter guidance negatively impacted investor sentiment, leading to a more than 7% drop in shares during premarket trading [1] Financial Performance - Adjusted earnings per share were $0.89, surpassing the consensus estimate of $0.86 [1] - Revenue increased by 10.4% year over year to $802.3 million, exceeding analyst expectations of $785.68 million [1] Subscription and Advertising Revenue - Digital subscription revenue rose by 13.9% to $381.5 million, driven by the addition of approximately 450,000 net digital-only subscribers during the quarter, bringing total subscribers to 12.78 million [2] - Digital advertising revenue surged by 24.9% to $147.2 million, supported by strong marketer demand and expanded ad inventory [2] Profitability Metrics - Operating profit increased by 10.2% to $161.6 million, while adjusted operating profit rose by 12.8% to $192.3 million [3] - Adjusted operating margin expanded to 24.0%, up roughly 50 basis points from a year earlier [3] Future Guidance - The company forecasts first-quarter 2026 digital-only subscription revenue growth of 14% to 17% and total subscription revenue growth of 9% to 11% [3] - Digital advertising revenue is expected to grow in the high-teens to low-twenties percentage range [3]
Chief Justice now requiring Supreme Court employees to sign NDA: NYT
MSNBC· 2026-02-04 20:30
Justice Scalia used to have a very stern talk with new clerks, and he would say, if you ever leak information, now or any point in your lifetime, about what happened in this court. I will hunt you down and destroy your career. Jokingly but only partly that right there Amy Justice Amy Coney Barrett describing how seriously the Supreme Court takes confidentiality and according to new reporting from the New York Times the court is now backing IT UP WITH A FORMAL CONTRACT.FOLLOWING A SERIES OF LEAKS, CHIEF JUST ...
OS Therapies Applauds Reauthorization of Pediatric Priority Review Voucher Program to Advance Breakthrough Osteosarcoma Immunotherapies
TMX Newsfile· 2026-02-04 17:45
Core Insights - OS Therapies Inc. celebrates the passage of the Mikaela Naylon Give Kids A Chance Act, which aims to enhance research and therapeutic access for pediatric cancer patients, particularly those with osteosarcoma [1][5] - Pediatric cancers are the leading cause of disease-based death among children in the U.S., highlighting the urgent need for innovative treatments [2] - The reauthorization of the Rare Pediatric Disease Designation (RPDD) Priority Review Voucher (PRV) program allows OS Therapies to extend its timeline for submitting a Biologics License Application (BLA) for its lead product, OST-HER2, until September 30, 2029 [3][6] Company Developments - OS Therapies is focused on developing listeria-based cancer immunotherapies, with OST-HER2 being its lead asset, which has shown positive results in clinical trials for recurrent pulmonary metastatic osteosarcoma [7] - The company is also evaluating other pipeline products for potential PRV opportunities and benefits under the FDA Platform Technology Designation Program [4] - OST-HER2 has received multiple designations from regulatory bodies, including Orphan Disease Designation and Fast Track Designation, which facilitate its development and potential market entry [6][7] Future Prospects - The company is advancing its next-generation Antibody Drug Conjugate (ADC) platform, known as tunable ADC (tADC), which utilizes proprietary technology for enhanced drug delivery [8] - OS Therapies is committed to transforming the lives of children and teens affected by osteosarcoma and other rare cancers, building on the legacy of patients like Mikaela Naylon [5]
New York Times reports strong 2025 growth as Washington Post cuts staff
Proactiveinvestors NA· 2026-02-04 16:58
Group 1 - Proactive provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [2] - The news team covers medium and small-cap markets, as well as blue-chip companies, commodities, and broader investment stories [3] - Proactive's content includes insights across various sectors such as biotech, pharma, mining, natural resources, battery metals, oil and gas, crypto, and emerging technologies [3] Group 2 - Proactive is committed to adopting technology to enhance workflows and content production [4] - The company utilizes automation and software tools, including generative AI, while ensuring all content is edited and authored by humans [5]